Quick Links
Sponsor
Media Partners
































Theme: Recent Innovations and Benchmark Practices in Vaccines & Vaccination

OMICS Publishing Group, the world leader for contributing its prominent scientific services by organizing more than 100 International Conferences across the World and managing 350 peer-reviewed open access journals in science, health, and technology.  Furthermore, OMICS Group has been associated with 100 more International scientific and technological societies and associations. The potential support from these International societies harness strong network development with the scientific core. OMICS Group Meetings hosts presentations from eminent experts in all the relevant fields and conducts International Workshops and International Symposiums.

With the overwhelming success of previous annual Vaccines conferences, OMICS Group welcomes you to attend the 4th International Conference on Vaccines & Vaccination, during September 24-26, 2014 at Valencia, Spain.

Vaccines 2014 This meeting will be the latest in a series of successful annual vaccine meetings organized by the OMICS Group Meetings that seek to bring together vaccine stakeholders including academic researchers, public health clinicians, vaccine policy makers, corporate and vaccine manufacturers. In association with the Vaccines-2014 meeting there will be opportunities for those selected to present at the meeting to also publish a manuscript from their talk in the Journal of Vaccines and Vaccination or its sister publication Immunome Research..

Vaccines-2014 anticipates more than 600 thought provoking presentations and eminent Keynote lectures. The attending delegates include Editorial Board Members of featured OMICS Group Journals. This is an excellent opportunity for the participants from Universities, Institutes and other Private Organizations to interact with the World class Scientists and renowned speakers.

The scientific sessions of the Vaccines & Vaccination conference housing all the current research in vaccines & vaccination research. Polio Vaccine will focus regarding free polio vaccine world; Cancer Vaccine will focus on translating cancer biology research into novel oncology treatments. Cancer imaging; HIV/AIDS Vaccine Human clinical trial of SAV001 prophylactic HIV vaccine and a new strategy for the development of therapeutic HIV vaccine: HPV Vaccines HPV Testing in Histological Specimens; Biodefense Vaccine, Therapeutic Vaccine and more other related topics discussed in this prestigious scientific meeting. This forum enables a common platform for the participants to discuss their research in order to establish a scientific network between the academia and industry leads to foster collaboration and to evaluate the emerging issues, technologies and innovations leads to explore new possibilities and improving the existed opportunities.
 

OMICS Group Vaccines 2014 Scientific Conference is sponsored by Sanofi Pasteur, France; GenPhar Inc., USA and Vaccinogen Inc., USA. With the support of Local Organizing Committee and International Organizing Committee we anticpate more than 600 participants from all over the world.

Keynote Presentations

Alexander von Gabain: "How to foster innovation to meet the global gap of novel vaccines: Leanings from the European Institute of Innovation and Techonolgy, EIT"

Nikolai Petrovsky: "Vaccine Adjuvants; the good, the bad and the ugly"

Michael G. Hanna: "The practical influence of tumor genomic heterogeneity on active specific immunotherapy"

Keynote Speakers
Roy Curtiss III
Director
Infectious Diseases and Vaccinology, USA
 
Alexander von Gabain
European Institute of Innovation and Technology, Europe
 
Nikolai Petrovsky
Editor In Chief
Journal of Vaccines & Vaccination
Flinders University
Australia
 
Michael G. Hanna
Chairman and CEO
Vaccinogen, Inc.
USA
Conference Highlights

Vaccine adjuvants

Veterinary vaccines

Therapeutic vaccines for chronic infections

Cancer vaccines

Biodefense vaccine

AIDS/HIV vaccine

Vaccine antigen modeling

Immuno-informatics in vaccine design

Vaccine formulation issues

Unconventional vaccines

To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
Conference Date
September 24-26, 2014
Sponsors & Exhibitors
Speaker Opportunity
Day 1                Day 2                Day 3
 
Available         Available         Available
Poster Opportunity
Special Issues
All accepted abstracts will be published in respective OMICS Group Journals.
Abstracts will be provided with Digital Object Identifier by
Participants List from Academia
University of Montreal, Canada
 
University of Washington, USA
 
Tanzania Vaccine Institute, Tanzania
 
Alexandria University, Egypt
 
Lanzhou Veterinary Research Institute, China
 
Sassari University School of Medicine, Italy
 
The University of Melbourne, Australia

Technical University of Braunschweig, Germany

Tsukuba Primate Research Center, Japan

Vaccines and Sera Torlak, Serbia

Emory University, USA

Faculdade de Medicina Santo, Brazil

Centro de Ingenieria Genetica y Biotecnologia, Cuba

University of KwaZulu-Natal, Belgium

National Health Research Institute, Taiwan

Korea University, Korea

Center for Genetic Engineering and Biotechnology, Cuba

Indonesian Technical Advisory Committee on Immunization, Indonesia

Walter Reed Army Institute of Research, USA

USAMRIID, USA

Karolinska Institutet, Sweden

Gulu University, Uganda

The Royal Children’s Hospital, Australia

University of Groningen, Netherlands

Central Institute for Research on Goats, India

INSERM, France

University of Sarajevo, Bosnia and Herzegovina

University of British Columbia, Canada

Temple University Center for Biotechnology, USA

UC Davis School of Medicine, USA

The Scripps Research Institute, USA

The University of Tokyo, Japan

Texas Biomedical Research Institute, USA

Flinders University, Australia

The George Washington University, USA

The University of Adelaide, South Australia

University of Michigan Medical School, USA

University of Louisville, USA

JJ Strossmayer University, Croatia
 
Tehran University of Medical Sciences, Iran
 
Medical University of Vienna, Austria
 
University of Bedfordshire, UK
 
Pasteur Institute of Iran, Iran
 
Palacky University, Czech Republic
 
The University of Western Ontario, Canada
 
Chonbuk National University, South Korea
Participants List from Business

Liquidia Technologies Inc., USA

Profectus BioSciences, Inc., USA

Prokarium Ltd., UK

FluGen Inc., USA

Novartis Vaccines, USA

Merck & Co., Inc., USA

Arbovax Inc., USA

Merck Millipore, Europe

Bavarian Nordic, Germany

VALNEVA, Austria

Cellular Technology Limited, USA

Celldex Therapeutics, USA

Serum Institute of India, India

Vedantra Pharmaceuticals, USA

Shanghai Zerun Biotechnology Co .,Ltd. China

GenPhar Inc., USA

InnaVirVax, USA

West Pharmaceutical Services, USA

Inovio Pharmaceuticals, USA

European Institute of Innovation and Technology, Europe

REIMS, France

International Vaccine Institute, Korea

Micronutrient Initiative, Bangladesh

Slovak Academy of Sciences, Solvakia

Best viewed in Mozilla Firefox | Google Chrome | Opera | Safari | Above IE 7.0 version